MCID: BLL003
MIFTS: 53

Bell's Palsy

Categories: Eye diseases, Infectious diseases, Neuronal diseases, Rare diseases, Smell/Taste diseases
Data Licensing
For inquiries, contact:

Aliases & Classifications for Bell's Palsy

MalaCards integrated aliases for Bell's Palsy:

Name: Bell's Palsy 11 19 52 75 5 41 14 16
Bell Palsy 11 19 43 71 31 33
Facial Nerve Palsy 19 33
Facial Paralysis 19 71
Facial Palsy 19 33
Seventh Cranial Nerve Paralysis 33
Facial Cranial Nerve Paralysis 19
Idiopathic Facial Palsy 19
Facial Nerve Paralysis 33
Refrigeration Palsy 19
Face Paralysis Nos 33
Bell's Palsy 11
Antoni's Palsy 19

Classifications:



External Ids:

Disease Ontology 11 DOID:12506
ICD9CM 34 351.0
MeSH 43 D020330
SNOMED-CT 68 193093009
ICD10 31 G51.0
ICD11 33 2004402146
UMLS 71 C0015469 C0376175

Summaries for Bell's Palsy

NINDS: 52 Bell's palsy is a form of temporary facial paralysis resulting from damage or trauma to the 7th cranial nerve, one of the facial nerves. It is the most common cause of facial paralysis. Generally, Bell's palsy affects only one side of the face, but it can affect both sides. Symptoms vary among individuals and include sudden weakness on one side of the face, drooping eyelid or corner of the mouth, drooling, inability to close the eye or mouth, altered taste, and excessive tearing in the eye. Symptoms appear suddenly and reach their peak within 72 hours. Bell's palsy can range in severity from mild weakness to total paralysis, and can cause significant facial distortion. The exact cause of Bell's palsy isn't known, but many scientists believe that reactivation of a dormant viral infection can cause the facial nerve to swell and become inflamed. Several other conditions can cause facial paralysis that might be diagnosed as Bell's palsy. The disorder can affect anyone at any age. Risk factors include pregnancy, preeclampsia, obesity, hypertention, diabetes, and upper respiratory ailments.

MalaCards based summary: Bell's Palsy, also known as bell palsy, is related to lyme disease and herpes zoster, and has symptoms including tremor, muscle weakness and back pain. An important gene associated with Bell's Palsy is MARVELD1 (MARVEL Domain Containing 1), and among its related pathways/superpathways are Hematopoietic Stem Cells and Lineage-specific Markers and Th17 Differentiation. The drugs Valaciclovir and Acetylcholine have been mentioned in the context of this disorder. Affiliated tissues include eye, bone and salivary gland, and related phenotype is cellular.

MedlinePlus: 41 Bell's palsy is the most common cause of facial paralysis. It usually affects just one side of the face. Symptoms appear suddenly and are at their worst about 48 hours after they start. They can range from mild to severe and include: Twitching Weakness Paralysis Drooping eyelid or corner of mouth Drooling Dry eye or mouth Excessive tearing in the eye Impaired ability to taste Scientists think that a viral infection makes the facial nerve swell or become inflamed. You are most likely to get Bell's palsy if you are pregnant, diabetic or sick with a cold or flu. Three out of four patients improve without treatment. With or without treatment, most people begin to get better within 2 weeks and recover completely within 3 to 6 months. NIH: National Institute of Neurological Disorders and Stroke

GARD: 19 Bell's palsy is a form of temporary facial paralysis which results from damage or trauma to one of the facial nerves. Symptoms vary, but may include twitching, weakness, drooping eyelid or corner of the mouth, drooling, dry eye or mouth, impairment of taste, and excessive tearing in the eye. The exact cause is unknown.

Disease Ontology: 11 A facial paralysis resulting from dysfunction in the cranial nerve VII (facial nerve).

Wikipedia: 75 Bell's palsy is a type of facial paralysis that results in a temporary inability to control the facial... more...

Related Diseases for Bell's Palsy

Diseases related to Bell's Palsy via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 1486)
# Related Disease Score Top Affiliating Genes
1 lyme disease 31.6 TNF IL6 CRP
2 herpes zoster 31.3 TLR3 CD8A CD4
3 melkersson-rosenthal syndrome 30.6 TNF CRP ACE
4 intracranial abscess 30.6 CRP CD4
5 pfeiffer syndrome 30.5 TNF CRP CD8A CD4
6 guillain-barre syndrome 30.5 TNF MBP ALB
7 brain stem infarction 30.5 LIPN CRP
8 pityriasis rosea 30.4 CD8A CD4 ACE2
9 uveoparotid fever 30.4 CD4 ACE
10 mononeuritis multiplex 30.3 TNF CRP CD4
11 syphilitic meningitis 30.3 CRP CD4
12 hepatitis e 30.3 TNF TLR3 ALB
13 tick-borne encephalitis 30.2 TLR3 CD8A CD4
14 multiple cranial nerve palsy 30.2 CRP CD4 ACE
15 neuritis 30.2 TNF MBP IL6
16 panniculitis 30.2 CRP CD8A CD4
17 central nervous system tuberculosis 30.1 TNF CRP CD4
18 tuberculoid leprosy 30.1 TNF CD8A CD4
19 parotitis 30.1 CRP CD8A CD4 ALB
20 lepromatous leprosy 30.1 TNF CD8A CD4
21 cerebellopontine angle tumor 30.1 KANTR FKBP4
22 severe acute respiratory syndrome 30.1 TNF IL6 CRP ACE2 ACE
23 viral infectious disease 30.1 TNF TLR3 IL6 CD4 ACE2
24 cavernous sinus thrombosis 30.0 CRP CD4 ACE2
25 hypertensive encephalopathy 30.0 CRP ALB ACE
26 tolosa-hunt syndrome 30.0 CRP ACE
27 hepatitis a 30.0 TNF TLR3 CD4 ALB
28 cat-scratch disease 30.0 CRP CD4 ACE
29 otitis media 30.0 TNF IL6 CRP ALB
30 covid-19 29.9 TNF IL6 CRP ACE2 ACE
31 neuroretinitis 29.9 CRP CD4 ACE
32 xerophthalmia 29.9 TNF MTRNR2L5 CRP CD8A CD4
33 eclampsia 29.9 TNF IL6 ALB ACE
34 abducens palsy 29.9 KANTR CRP
35 granulomatosis with polyangiitis 29.9 TNF CRP CD8A CD4
36 superior mesenteric artery syndrome 29.9 CRP ALB
37 osteomyelitis 29.9 TNF IL6 CRP
38 nerve compression syndrome 29.9 LIPN IL6 CRP ALB
39 vitiligo-associated multiple autoimmune disease susceptibility 1 29.8 TNF CD8A CD4
40 pre-eclampsia 29.8 TNF IL6 CRP ALB ACE
41 chlamydia 29.8 TNF IL6 CRP
42 renal hypertension 29.8 CRP ALB ACE
43 polyarteritis nodosa 29.8 TNF IL6 CRP
44 aortic valve insufficiency 29.8 CRP ALB ACE
45 otitis externa 29.8 IL6 CRP CD4
46 amyloidosis 29.8 TNF IL6 CRP ALB
47 mononeuropathy 29.8 TNF IL6 CRP CD4 ALB ACE
48 rubella 29.8 TNF TLR3 IL6
49 human cytomegalovirus infection 29.7 TNF IL6 CD8A CD4
50 japanese encephalitis 29.7 TLR3 CD8A CD4

Graphical network of the top 20 diseases related to Bell's Palsy:



Diseases related to Bell's Palsy

Symptoms & Phenotypes for Bell's Palsy

UMLS symptoms related to Bell's Palsy:


tremor; muscle weakness; back pain; ophthalmoplegia; headache; syncope; generalized muscle weakness; hemiplegia; pain; chronic pain; sciatica; seizures; vertigo/dizziness; sleeplessness; oral manifestations; facial paresis; facial palsy, upper motor neuron; facial palsy, lower motor neuron; hemifacial paralysis; flaccid muscle tone

MGI Mouse Phenotypes related to Bell's Palsy:

45
# Description MGI Source Accession Score Top Affiliating Genes
1 cellular MP:0005384 9.36 ACE ACE2 ALB CD4 CD8A FKBP4

Drugs & Therapeutics for Bell's Palsy

Drugs for Bell's Palsy (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 64)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Valaciclovir Approved, Investigational Phase 4 124832-27-5, 124832-26-4 60773 135398742
2
Acetylcholine Approved, Investigational Phase 4 51-84-3 187
3
Prednisolone phosphate Approved, Vet_approved Phase 4 302-25-0
4
Prednisolone acetate Approved, Vet_approved Phase 4 52-21-1
5
Prednisolone Approved, Vet_approved Phase 4 50-24-8 4894 5755
6
Methylprednisolone hemisuccinate Approved Phase 4 2921-57-5 1875
7
Methylprednisolone Approved, Vet_approved Phase 4 83-43-2 4159 6741
8
Apraclonidine Approved Phase 4 66711-21-5 2216
9
Lidocaine Approved, Vet_approved Phase 4 137-58-6 3676
10
Prednisolone hemisuccinate Experimental Phase 4 2920-86-7 4897
11
Cortisone Experimental Phase 4 53-06-5 222786
12 Neuroprotective Agents Phase 4
13 Antiemetics Phase 4
14 Gastrointestinal Agents Phase 4
15
abobotulinumtoxinA Phase 4
16 Botulinum Toxins, Type A Phase 4
17 Botulinum Toxins Phase 4
18
incobotulinumtoxinA Phase 4
19 Cholinergic Agents Phase 4
20 Antineoplastic Agents, Hormonal Phase 4
21 Hormones Phase 4
22 Hormone Antagonists Phase 4
23 glucocorticoids Phase 4
24 Anti-Inflammatory Agents Phase 4
25
Methylprednisolone Acetate Phase 4 584547
26 Neurotransmitter Agents Phase 4
27 Adrenergic alpha-Agonists Phase 4
28 Adrenergic Agonists Phase 4
29 Adrenergic Agents Phase 4
30 Anesthetics Phase 4
31 Anti-Arrhythmia Agents Phase 4
32 Sodium Channel Blockers Phase 4
33 Anesthetics, Local Phase 4
34 Diuretics, Potassium Sparing Phase 4
35
Dexamethasone acetate Approved, Investigational, Vet_approved Phase 2, Phase 3 1177-87-3 3680
36
Dexamethasone Approved, Investigational, Vet_approved Phase 2, Phase 3 50-02-2 3003 5743
37
Phenol Approved, Experimental Phase 2, Phase 3 108-95-2 996
38
Benzocaine Approved, Investigational Phase 2, Phase 3 1994-09-7, 94-09-7 2337
39
Tannic acid Approved Phase 2, Phase 3 1401-55-4 16129878 16129778
40 Pharmaceutical Solutions Phase 2, Phase 3
41
Hyaluronic acid Approved, Vet_approved Phase 2 9004-61-9 53477741
42
Nimodipine Approved, Investigational Phase 2 66085-59-4 4497
43 Protective Agents Phase 2
44 Adjuvants, Immunologic Phase 2
45 Viscosupplements Phase 2
46 Immunologic Factors Phase 2
47 Antihypertensive Agents Phase 2
48 Vasodilator Agents Phase 2
49 Calcium, Dietary Phase 2
50 calcium channel blockers Phase 2

Interventional clinical trials:

(show top 50) (show all 75)
# Name Status NCT ID Phase Drugs
1 A Multicentre Placebo-Controlled Evaluation of Prednisolone and/or Valaciclovir for the Treatment of Bell's Palsy Completed NCT00510263 Phase 4 Prednisolone + placebo;Valaciclovir + placebo;Prednisolone + valaciclovir;Placebo + placebo
2 Mixed Methods Investigation of Chronic Facial Paralysis in Individuals With Synkinesis: Study of Outcomes Before and After Treatment Completed NCT04148872 Phase 4 Chemodenervation (4 months)
3 Randomized, Single-blind Comparison of Three Commercially Available Botulinum Neuromodulators in the Management of Facial Synkinesis Completed NCT03048383 Phase 4 OnabotulinumtoxinA Injectable Product;AbobotulinumtoxinA Injectable Product;Incobotulinumtoxin A Injectable Product
4 Do We Need to Taper Down Steroid Therapy for Bell's Palsy: A Prospective Randomized Controlled Trial Recruiting NCT04406376 Phase 4 Prednisone tablet
5 The Facial Nerve Palsy And Cortisone Evaluation (FACE) Study in Children: A Randomized Double-blind, Placebo-controlled, Multicenter Trial Recruiting NCT03781700 Phase 4 Prednisolone;Placebo Oral Tablet
6 Efficacy of Topical Apraclonidine for the Treatment of Ocular Synkinesis Not yet recruiting NCT05167760 Phase 4 Apraclonidine
7 Study of the Reinnervation of Facial Muscles After Lengthening Temporalis Myoplasty Terminated NCT01833221 Phase 4 injection of 1% lidocaine, 2mL for facial nerve block
8 Assessment of Corticosteroid Effect in the Prevention of Facial Palsy After Cerebella-pontine Angle Surgery Completed NCT00438087 Phase 3 methylprednisolone
9 Intratympanic Steroid Injection for Treatment of Idiopathic Facial Nerve Paralysis Recruiting NCT03508440 Phase 2, Phase 3 Prednisone
10 A Phase 2a, Multicenter, Randomized, Subject and Evaluator Blinded, Controlled Study Evaluating the Safety and Efficacy of NTX-001 Compared to Standard of Care in the Treatment and Prevention of Facial Paralysis Requiring Surgical Repair. Recruiting NCT05293522 Phase 2
11 Clinical, Instrumental and Histological Evaluation of the Combined Use of Onabotulinumtoxin A and Hyaluronic Acid Fillers in Patients With Facial Paralysis Recruiting NCT05012566 Phase 2 Vistabex
12 Intraoperative Application of Nimodipine to the Facial and Cochlear Nerves During Vestibular Schwannoma Resection to Avoid Spasm-related Postoperative Facial Paralysis and Deafness - a Prospective Randomized Pilot Study Recruiting NCT04801953 Phase 2 NiMODipine Injectable Solution
13 Mimetic Interfaces - Toispuoleisen Kasvohermohalvauksen Kojeellinen Kuntoutus Terveen Puolen Lihasaktiviteettiohjauksella. Stimulaattorin Prototyypin Testaus terveillä koehenkilöillä ja Kasvohermohalvauspotilailla. Unknown status NCT03496025 Phase 1
14 Prednisone Acetate and Acupuncture for the Treatment of Facial Neuritis: a Multiple Center, Comparative Effectiveness Research in China Unknown status NCT01201642 Prednisolone
15 Study of Psychological Factors on the Occurence of Bell's Palsy Unknown status NCT01377766
16 Surgery or Clinical Follow-up in Patients With Bell's Palsy. A Prospective, Parallell, Single Center, Randomized , Open Surgery Clinical Study. Unknown status NCT02179684
17 Intratympanic Stereoidal Injections for Facial Nerve Palsy Unknown status NCT03371589 Dexamethasone
18 Ancillary Procedures in Patients of Refractory Facial Palsy Patients Selection and Evaluation of the Outcomes Unknown status NCT04237961
19 Validation of a French-language Version of Specific Quality of Life Questionnaires in Patients With Peripheral Facial Palsy Unknown status NCT03581253
20 Comparative Study of Peripheral Facial Paralysis Sequelae Based on the Initial Medical Care of Lyme Disease Among Children Unknown status NCT03981874
21 Reliability of Multislice Computed Tomography Scan in Cases With Facial Nerve Paralysis Due to Temporal Bone Trauma Unknown status NCT03469427
22 Photobiomodulation Therapy for Idiopathic Facial Paralysis: Randomized Trial Controlled Completed NCT05585346 Prednisolone Acetate
23 Study of Effects of Deqi and Neuropsychological Factors on Acupuncture Effects in Treatment of Bell's Palsy Completed NCT00685789
24 A New Clinical Therapy for Bell's Palsy Completed NCT01686464 prednisone and valacyclovir treatments
25 Studying of Acupuncture for Bell's Palsy According to Different Stages Completed NCT00608660
26 Electro Physiological Responses to Kabat Motor Control Re-education on Bell's Palsy: A Randomized Controlled Study Completed NCT04894513
27 Effects of Kabat Technique and Neuromuscular Re-Education in Patients With Bell's Palsy Completed NCT04807491
28 EFFECTIVENESS OF PULSED ULTRASOUND TREATMENT ON PATIENT WITH BELL'S PALSY, A DOUBLE-BLIND, RANDOMİZED, PLACEBO-CONTROLLED TRIAL Completed NCT04412733
29 Effects of Mirror Therapy Application of Tablet pc on Acute Bell's Palsy. Completed NCT04936152
30 Ultrasound-Guided Stellate Ganglion Block With Botulinum Toxin Versus Steroid in Refractory Bell's Palsy Completed NCT05099835 Botox;triamcinolonacetonide
31 Stellate Gnaglion Block Versus Conventional Therapey in Refractory Bell's Palsy; A Rondomized Single Blind Clinical Trial Completed NCT05094245
32 Effect of Neural Mobilization in Bells Palsy: A Randomized Controlled Trial Completed NCT04280120
33 Effect of Laser Acupuncture Treatment on Chronic Facial Paralysis: A Randomized Sham Control, Double Blind Pilot Study Completed NCT03592797
34 Function and Form Outcomes in Patients With Facial Paralysis Completed NCT03974763
35 The Role of Collagen in the Rehabilitation of Peripheral Paralysis of the Facial Nerve Completed NCT04353908
36 Photobiomodulation Therapy for Facial Paralysis Over 8 Weeks: An Open-Label Pilot, Non-concurrent Control Study Completed NCT05585333
37 Non-surgical Correction of Eye Lid Paralysis With External Magnet Systems Completed NCT02988856
38 Lengthening Temporalis Myoplasty and Improvement of Primary Swallowing Disorders in Facial Paralysis Completed NCT03284125
39 Assessment of the Cross-face Nerve Graft in the Treatment of Facial Paralysis Completed NCT03006783
40 Improvement of Facial Symmetry With Myofunctional Therapy Combined to Botulinum Toxin Injections in Long Standing Facial Paralysis Completed NCT00989209 Botulinum Toxin Type A
41 Antiviral Treatment in Facial Palsy. Randomized Control Trial Completed NCT02328079 Steroids (Prednisolone) and Steroids plus Antiviral (Prednisolone + acyclovir)
42 Production et Perception émotionnelle Chez Les Patients paralysés Faciaux: Marqueurs Respiratoires, Phonatoires et expressivité Faciale. Completed NCT03619720
43 Post-parotidectomy Facial Paresis: Intraoperative and Postoperative Factors Completed NCT02527226
44 The Role of MyotonPro in Assessing the Biomechanical Properties of Facial Muscles in Facial Paralysis Patients and Its Role in Monitoring Recovery Following Facial Reanimation Surgery Completed NCT02489162
45 Anthropometric Angular Measurement to Determine Muscle Tonus in Patients With Peripheral Facial Paralysis Completed NCT00903669
46 Treatment Bell´s Palsy: Prednisone vs Prednisone Valacyclovir Completed NCT00561106 prednisone- valacyclovir;prednisone-placebo
47 Effect of Stellate Ganglion Block Combined With Facial Nerve Block on the Treatment of Idiopathic Facial Paralysis Completed NCT04800666 Mecobalamin Tablets
48 A Pilot Study Evaluating the Effectiveness of Information and Therapy Guides for Improving the Psychosocial Wellbeing of People With Facial Palsy. Completed NCT03943953
49 Comparison of Motor Imagery Technique and Mime Therapy on Facial Expressions in Facial Palsy Patients; A Randomized Clinical Trial Completed NCT04993417
50 Pilot Study Assessing Cognitive Function and Emotional Possessing in Patients With Bilateral Facial Palsy Completed NCT02179450

Search NIH Clinical Center for Bell's Palsy

Inferred drug relations via UMLS 71 / NDF-RT 50 :


Scopolamine
Scopolamine Hydrobromide

Cochrane evidence based reviews: bell palsy

Genetic Tests for Bell's Palsy

Anatomical Context for Bell's Palsy

Organs/tissues related to Bell's Palsy:

MalaCards : Eye, Bone, Salivary Gland, Skin, Brain, Skeletal Muscle, Tongue

Publications for Bell's Palsy

Articles related to Bell's Palsy:

(show top 50) (show all 13997)
# Title Authors PMID Year
1
Clinical use of thread embedding acupuncture for facial nerve palsy: A web-based survey. 62 41
36451397 2022
2
Bell's palsy misdiagnosis: characteristics of occult tumors causing facial paralysis. 62 41
36258246 2022
3
Bell's Palsy: Etiology, Management and Dental Implications. 62 41
36322635 2022
4
Posterior reversible encephalopathy syndrome (PRES): Should more attention be paid to the atypical forms? 62
36457790 2023
5
Sural Nerve Vertical Cross-Face Graft for Lacrimal Gland Neurotization to Improve Tear Secretion in Neurodeprivative Dry Eye. 62
36459583 2023
6
Association Between Clinical Symptoms, Electrodiagnostic Findings, Clinical Outcome, and Prodromal Symptoms in Patients With Bell's Palsy. 62
35109694 2023
7
Epidemiology, clinical features, and treatment modalities of facial nerve palsy in COVID-19 patients: a systematic review. 62
35917018 2022
8
Bilateral facial palsy as the first sign of HIV infection. 62
35945381 2022
9
Therapists' perceptions and attitudes in facial palsy rehabilitation therapy: A mixed methods study. 62
33890851 2022
10
Effectiveness of multiwave locked system laser on the treatment of patients with idiopathic Bell's palsy: a randomized double-blind placebo controlled trial. 62
35881208 2022
11
Ruptured bilateral middle cerebral artery aneurysms diagnosed based on cerebral vasospasm-associated ischemic symptoms: A case report. 62
36176966 2022
12
A case of head and neck cutaneous squamous cell carcinoma highlighting aggressive perineural features. 62
36189160 2022
13
Nocardia Farcinica Mastoiditis and Epidural Abscess in an Immunocompetent Patient: A Rare Entity. 62
36453208 2022
14
Surgical management of tympanojugular paragangliomas using the flexible CO2 laser. 62
35511294 2022
15
Trends and Outcomes of Fungal Temporal Bone Osteomyelitis: A Scoping Review. 62
36351221 2022
16
Cholesteatoma With Cochlear Fistula and Carotid Dehiscence. 62
36045486 2022
17
Enhancement of cranial nerves in Lyme neuroborreliosis: incidence and correlation with clinical symptoms and prognosis. 62
35608630 2022
18
Long-term results of upfront, single-session Gamma Knife radiosurgery for large cystic vestibular schwannomas. 62
36471101 2022
19
Asymmetric crying facies in an elderly, when a facial asymmetry is not a facial paralysis but a marker of possible congenital malformations: case report and review of the literature. 62
36456879 2022
20
Objective assessment of eyelid position and tear meniscus in facial nerve palsy. 62
34958290 2022
21
A post-marketing safety assessment of COVID-19 mRNA vaccination for serious adverse outcomes using administrative claims data linked with vaccination registry in a city of Japan. 62
36371366 2022
22
ELN missense variant in patient with mid-aortic syndrome case report. 62
36460951 2022
23
Physical rehabilitation of central facial palsy: A survey of current multidisciplinary practice. 62
34928754 2022
24
Selective Neurectomy for Treatment of Post-Facial Paralysis Synkinesis: A Systematic Review. 62
36155895 2022
25
Incidence and Management of Facial Paralysis After Skull Base Trauma, an Administrative Database Study. 62
36214506 2022
26
Therapeutic strategy for facial paralysis based on the combined application of Si-based agent and methylcobalamin. 62
36438600 2022
27
Effect of the acupuncture within 24 hour after the onset of peripheral facial paralysis. 62
35850903 2022
28
Ectopic thymic carcinoma of the parotid gland. 62
35339333 2022
29
Is There a Role for Cerebral Ultrasonography in Near-Term/Term Neonates Following Assisted Vaginal Delivery? A Prospective, Single-Center Study. 62
32911558 2022
30
Axonal Regeneration Through Autologous Grafts: Does the Axonal Load Influence Regeneration? 62
36037615 2022
31
Coronavirus-associated mucormycosis: different from sinonasal mucormycosis. 62
35791976 2022
32
Comparative analysis of benign and malignant parotid gland tumors: A retrospective study of 992 patients. 62
36473266 2022
33
Superficial versus total parotidectomy for recurrent pleomorphic adenoma in the parotid gland. 62
36067593 2022
34
Predicting Depressor Anguli Oris Excision Outcomes Using Local Muscle Block. 62
36378249 2022
35
Does preoperative gamma knife treatment affect the result of microresection of vestibular schwannoma? 62
36316569 2022
36
Maxillofacial Skeleton and Facial Anatomy. 62
36244720 2022
37
Hemifacial Spasm Caused by Distal Neurovascular Compression Confirmed by Lateral Spread Response Monitoring. 62
36409872 2022
38
Dual-Innervated Free Gracilis Muscle Transfer for Facial Reanimation in Children. 62
36279580 2022
39
Treatment, Survival, and Demographics in Temporal Bone Malignancies: A Pooled Data Analysis. 62
36452912 2022
40
Aural tuberculosis at the start of the 21st century. Literature review according to SWiM guidelines. Part 2: Treatment. 62
35778340 2022
41
Delayed Facial Nerve Paralysis After Vestibular Schwannoma Resection. 62
36379361 2022
42
Totally Endoscopic Transcanal Facial Nerve Decompression in Patients with Traumatic Facial Nerve Paralysis: from Geniculate Ganglion to Mastoid Segment. 62
36382446 2022
43
Thematic Analysis of Canadian Patient-Reported Outcomes in Facial Nerve Paralysis: A Combined Interpretive Description and Modified Delphi Approach. 62
35486834 2022
44
Tri-Vector Gracilis Microneurovascular Free Tissue Transfer with Periocular Component to Achieve a Duchenne Smile in Patients with Facial Paralysis. 62
36265011 2022
45
Commentary on: "Tri-Vector Gracilis Microneurovascular Free Tissue Transfer with Periocular Component to Achieve a Duchenne Smile in Patients with Facial Paralysis" by Byrne et al. 62
36264588 2022
46
Does SARS-CoV2 vaccine exposure trigger acute-onset polyradiculopathy characterized by more common facial paralysis? 62
36059144 2022
47
Automatic Analysis of Asymmetry in Facial Paralysis Patients Using Landmark-Based Measures. 62
35271372 2022
48
Pintail Comb Injury as a Rare Cause of Penetrating Temporal Bone Trauma With Facial Paralysis. 62
33172309 2022
49
Analysis of Risk Factors and Prediction Model for Recurrence of Hemifacial Spasm After Radiofrequency Ablation. 62
36375197 2022
50
Symptoms and clinical features in patients affected by endolymphatic sac tumor: a systematic review and meta-analysis. 62
35704074 2022

Variations for Bell's Palsy

Expression for Bell's Palsy

Search GEO for disease gene expression data for Bell's Palsy.

Pathways for Bell's Palsy

GO Terms for Bell's Palsy

Biological processes related to Bell's Palsy according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 positive regulation of chemokine production GO:0032722 9.85 TNF TLR3 IL6
2 immune response GO:0006955 9.81 TNF TLR3 MBP IL6 CD8A CD4
3 negative regulation of signaling receptor activity GO:2000272 9.65 TNF MTRNR2L5 ACE2
4 regulation of systemic arterial blood pressure by renin-angiotensin GO:0003081 9.62 ACE2 ACE
5 positive regulation of interleukin-6 production GO:0032755 9.56 TNF TLR3 MBP IL6
6 negative regulation of lipid storage GO:0010888 9.1 TNF IL6 CRP

Molecular functions related to Bell's Palsy according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 peptidyl-dipeptidase activity GO:0008241 8.92 ACE2 ACE

Sources for Bell's Palsy

2 CDC
6 CNVD
8 Cosmic
9 dbSNP
10 DGIdb
16 EFO
17 ExPASy
18 FMA
19 GARD
27 GO
28 GTR
29 HMDB
30 HPO
31 ICD10
32 ICD10 via Orphanet
33 ICD11
34 ICD9CM
35 IUPHAR
36 LifeMap
38 LOVD
40 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
52 NINDS
53 Novoseek
55 ODiseA
56 OMIM via Orphanet
57 OMIM® (Updated 08-Dec-2022)
61 PubChem
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....